Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $15.11B.
ENTERPRISE VALUE (EV)
$15.11B
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Enterprise Value (EV)
$15.11B
Market Cap
$12.17B
Enterprise Value (EV)
$14.01B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | $15.11B |
| ICON Public Limited Company (ICLR)vs › | $12.89B | $15.45B |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | $13.09B |
| Baxter International Inc. (BAX)vs › | $12.52B | $20.04B |
| Penumbra, Inc. (PEN)vs › | $12.49B | $12.50B |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | $14.01B |
| Encompass Health Corporation (EHC)vs › | $12.00B | $14.73B |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | $13.75B |
| DaVita Inc. (DVA)vs › | $11.47B | $21.59B |
| Bio-Techne Corporation (TECH)vs › | $11.36B | $11.39B |
Market Cap
$12.95B
Total Debt
$2.72B
Cash
$570.12M
Enterprise Value
$15.11B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
